Jane Street Group, LLC Jaguar Health, Inc. Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.08 - $809.55 $1,820 - $18.4 Million	22,753 Added 101.72%	45,121 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.17 - $765.0 $3,802 - $17.1 Million	22,368 New	22,368 $3,000
Q3 2022 Nov 14, 2022	BUY	$0.17 - $765.0 $3,802 - $17.1 Million	22,368 New	22,368 $3,000
Q2 2022 Aug 16, 2022	SELL	$0.27 - $0.71 $8,962 - $23,567	-33,193 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$0.38 - $1.07 $30,347 - $85,452	-79,862 Reduced 70.64%	33,193 $23,000
Q4 2021 Feb 15, 2022	BUY	$1.03 - $2.48 $64,330 - $154,893	62,457 Added 123.44%	113,055 $118,000
Q3 2021 Nov 16, 2021	BUY	$2.14 - $4.95 $108,279 - $250,460	50,598 New	50,598 $115,000

Ticker JAGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 119,861,000
Market Cap $127M
Description
Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfecti...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.